WallStreetZenWallStreetZen

NASDAQ: VNDA
VANDA PHARMACEUTICALS INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VNDA

Based on 1 analyst offering 12 month price targets for VANDA PHARMACEUTICALS INC.
Min Forecast
$12.00+21.33%
Avg Forecast
$12.00+21.33%
Max Forecast
$12.00+21.33%

Should I buy or sell VNDA stock?

Based on 1 analyst offering ratings for VANDA PHARMACEUTICALS INC.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

VNDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Bottom 4%
4
HoldDowngrades$12.00+21.33%2022-02-25

1 of 1

Forecast return on equity

Is VNDA forecast to generate an efficient return?
Company
7.09%
Industry
124.21%
Market
32.71%
VNDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VNDA forecast to generate an efficient return on assets?
Company
5.9%
Industry
20.15%
VNDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VNDA earnings per share forecast

What is VNDA's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$0.30-9.09%
Avg 2 year Forecast
$0.46+39.39%
Avg 3 year Forecast
$0.60+81.82%
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

VNDA revenue forecast

What is VNDA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$265.1M-0.42%
Avg 2 year Forecast
$268.5M+0.86%
Avg 3 year Forecast
$272.0M+2.18%
VNDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VNDA earnings growth forecast

How is VNDA forecast to perform vs Biotechnology companies and vs the US market?
Company
22.28%
Industry
8.72%
Market
15.78%
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
VNDA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

VNDA revenue growth forecast

How is VNDA forecast to perform vs Biotechnology companies and vs the US market?
Company
0.72%
Industry
17.8%
Market
9.29%
VNDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VNDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VNDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VNDA$9.89$12.00+21.33%Hold
PHVS$16.70$45.00+169.46%Buy
KNSA$8.18$34.00+315.65%Strong Buy
RANI$11.18$23.67+111.69%Strong Buy
LBPS$3.17$38.50+1,114.51%Strong Buy
View Top Biotech Stocks

VANDA PHARMACEUTICALS Stock Forecast FAQ

Is VANDA PHARMACEUTICALS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VNDA) stock is to Hold VNDA stock.

Out of 1 analyst, 0 (0%) are recommending VNDA as a Strong Buy, 0 (0%) are recommending VNDA as a Buy, 1 (100%) are recommending VNDA as a Hold, 0 (0%) are recommending VNDA as a Sell, and 0 (0%) are recommending VNDA as a Strong Sell.

What is VNDA's earnings growth forecast for 2022-2024?

(NASDAQ: VNDA) VANDA PHARMACEUTICALS's forecast annual earnings growth rate of 22.28% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.72%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 15.78%.

VANDA PHARMACEUTICALS's earnings in 2022 is $18,072,000.On average, 1 Wall Street analyst forecast VNDA's earnings for 2022 to be $16,946,914, with the lowest VNDA earnings forecast at $16,946,914, and the highest VNDA earnings forecast at $16,946,914. On average, 1 Wall Street analyst forecast VNDA's earnings for 2023 to be $25,985,268, with the lowest VNDA earnings forecast at $25,985,268, and the highest VNDA earnings forecast at $25,985,268.

In 2024, VNDA is forecast to generate $33,893,827 in earnings, with the lowest earnings forecast at $33,893,827 and the highest earnings forecast at $33,893,827.

What is VNDA's revenue growth forecast for 2022-2024?

(NASDAQ: VNDA) VANDA PHARMACEUTICALS's forecast annual revenue growth rate of 0.72% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 17.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.29%.

VANDA PHARMACEUTICALS's revenue in 2022 is $266,205,000.On average, 1 Wall Street analysts forecast VNDA's revenue for 2022 to be $14,975,422,651, with the lowest VNDA revenue forecast at $14,975,422,651, and the highest VNDA revenue forecast at $14,975,422,651. On average, 1 Wall Street analysts forecast VNDA's revenue for 2023 to be $15,167,487,672, with the lowest VNDA revenue forecast at $15,167,487,672, and the highest VNDA revenue forecast at $15,167,487,672.

In 2024, VNDA is forecast to generate $15,365,201,664 in revenue, with the lowest revenue forecast at $15,365,201,664 and the highest revenue forecast at $15,365,201,664.

What is VNDA's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: VNDA) forecast ROA is 5.9%, which is lower than the forecast US Biotechnology industry average of 20.15%.

What is VNDA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VNDA price target, the average VNDA price target is $12.00, with the highest VNDA stock price forecast at $12.00 and the lowest VNDA stock price forecast at $12.00.

The Wall Street analyst predicted that VANDA PHARMACEUTICALS's share price could reach $12.00 by Feb 25, 2023. The average VANDA PHARMACEUTICALS stock price prediction forecasts a potential upside of 21.33% from the current VNDA share price of $9.89.

What is VNDA's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: VNDA) VANDA PHARMACEUTICALS's current Earnings Per Share (EPS) is $0.33. On average, analysts forecast that VNDA's EPS will be $0.30 for 2022, with the lowest EPS forecast at $0.30, and the highest EPS forecast at $0.30. On average, analysts forecast that VNDA's EPS will be $0.46 for 2023, with the lowest EPS forecast at $0.46, and the highest EPS forecast at $0.46. In 2024, VNDA's EPS is forecast to hit $0.60 (min: $0.60, max: $0.60).

What is VNDA's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: VNDA) forecast ROE is 7.09%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.